-+ 0.00%
-+ 0.00%
-+ 0.00%

THERIVA™ BIOLOGICS ANNOUNCES SALE OF SYN-004 (RIBAXAMASE) AND RELATED ANTIBIOTIC-DEGRADING ENZYME PORTFOLIO TO BIOSSIL LABS INC.

Reuters·11/02/2026 13:00:40

Please log in to view news